Skip to Main content Skip to Navigation
Journal articles

The role of RICTOR downstream of receptor tyrosine kinase in cancers

Abstract : AbstractThe importance of the network defined by phosphatidylinositol-3-kinase (PI3K), AKT and mammalian target of rapamycin (mTOR) downstream of Receptor Tyrosine Kinase (RTK) has been known for many years but the central role of RICTOR (rapamycin-insensitive companion of mTOR) in this pathway is only starting to emerge. RICTOR is critical for mTORC2 (the mammalian target of rapamycin complex 2) kinase activity and as such plays a key role downstream of RTK. Alterations of RICTOR have been identified in a number of cancer cell types and its involvement in tumorigenesis has begun to be unraveled recently. Here, we summarize new research into the biology of RICTOR signaling in cancers focusing on tumors with altered RTK. We show that, as a key signaling node and critical effector of RTKs, RICTOR is becoming a valuable therapeutic target in cancer with altered RTK.
Document type :
Journal articles
Complete list of metadata

Cited literature [61 references]  Display  Hide  Download
Contributor : BMC BMC Connect in order to contact the contributor
Submitted on : Sunday, February 25, 2018 - 5:17:51 AM
Last modification on : Tuesday, January 12, 2021 - 2:39:29 PM
Long-term archiving on: : Monday, May 28, 2018 - 4:24:35 PM


Publication funded by an institution




Ahlem Jebali, Nicolas Dumaz. The role of RICTOR downstream of receptor tyrosine kinase in cancers. Molecular Cancer, BioMed Central, 2018, 17 (1), pp.39. ⟨10.1186/s12943-018-0794-0⟩. ⟨inserm-01716891⟩



Record views


Files downloads